M. Leverkus

1.9k citations

28 papers · 1.4k indexed · h-index 19

Impact in

Immunology top 5%
- Immunotherapy and Immune Responses
- interferon and immune responses
- Immune Response and Inflammation
Dermatology top 5%

Papers in

Immunology 10
- Immunotherapy and Immune Responses 4
Dermatology 3

Co-authors: Henning Walczak E B Bröcker Thilo Mengling Manfred Neumann P H Krammer Charles T. Rauch Peter Geserick Sebastian Horn
Journals: British Journal of Dermatology (5 papers)Cell Death and Disease (3 papers)Journal of the European Academy of Dermatology and Venereology (3 papers)Cell Death and Differentiation (3 papers)Oncogene (2 papers)
Partner nations: Germany United States Netherlands

In The Last Decade

M. Leverkus

28 papers receiving 1.4k citations

Peers

Countries citing papers authored by M. Leverkus

Since Specialization

Citations

This map shows the geographic impact of M. Leverkus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Leverkus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Leverkus more than expected).

Fields of papers citing papers by M. Leverkus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Leverkus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Leverkus. The network helps show where M. Leverkus may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Leverkus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Leverkus Line = papers co-authored together M. Leverkus links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Successful treatment of bullous pemphigoid with omalizumab as corticosteroid‐sparing agent: report of two cases and review of literature Journal of the European Academy of Dermatology and Venereology ·Galina Balakirski, Asem Alkhateeb, Hans F. Merk, M. Leverkus, Mosaad Megahed	2016	51
2	Omalizumab-Treatment of therapy resistant bullous Pemphigoid RWTH Publications (RWTH Aachen) ·Galina Balakirski, M. Leverkus, Mosaad Megahed, Hans F. Merk	2015	2
3	TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis Cell Death and Disease ·Ingolf Karl, H. Grazikowske, Nadine Schmidt, Sebastian Horn, Matthias Goebeler, M. Leverkus, Harald Wajant, Tina Giner	2014	66
4	The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin Cell Death and Disease ·Peter Geserick, Sergio A. Urzúa, Maria Feoktistova, M. Leverkus	2014	28
5	Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy Leukemia ·Metodi V. Stankov, Mona El Khatib, Basant Kumar Thakur, Kirsten Heitmann, Diana Panayotova‐Dimitrova, Orlando Castañeda Alvarez, Jean‐Pierre Bourquin, Nóra Schweitzer, M. Leverkus, Karl Welte, Dirk Reinhardt, Zihan Li, Stuart H. Orkin, Georg M. N. Behrens, Jan‐Henning Klusmann	2013	101
6	Systems analysis of apoptosis protein expression allows the case-specific prediction of cell death responsiveness of melanoma cells Cell Death and Differentiation ·Egle Passante, Maximilian L. Würstle, Christian T. Hellwig, M. Leverkus, Markus Rehm	2013	27
7	Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their management Journal of the European Academy of Dermatology and Venereology ·谷田清一, talim fidoyilari, Sergij Goerdt, M. Leverkus, Jochen Utikal	2012	66
8	Late-onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VII British Journal of Dermatology ·M. Leverkus, Andreas Ambach, Wransky, Jürgen Kohlhase, Enno Schmidt, Hauke Schumann, Cristina Has, Harald Gollnick	2011	5
9	Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation Oncogene ·Manfred Neumann, IanA. Silver, Annette Wilisch-Neumann, Metheus CRUZ LIMA PEREIRA, Shyam M. Kavuri, M. Leverkus, Reinhard Kandolf, Monika C. Brunner‐Weinzierl, Karin Klingel	2011	19
10	Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells Cell Death and Differentiation ·Arnim Weber, Iryna Kovinchuk, Robert Besch, 熊劲刚, M. Leverkus, Georg Häcker	2009	116
11	Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis Oncogene ·Peter Geserick, Claudia Drewniok, Mike Hupe, Tobias L. Haas, Xiyue Zhou, Martin R. Sprick, Michael P. Schön, Frank Henkler, Harald Gollnick, Henning Walczak, M. Leverkus	2007	81
12	Bullous delayed pressure urticaria: pathogenic role for eosinophilic granulocytes? British Journal of Dermatology ·Andreas Kerstan, Christian Rosé, Dagmar Simon, Hans‐Uwe Simon, E B Bröcker, Axel Trautmann, M. Leverkus	2005	7
13	Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis? British Journal of Dermatology ·M. Leverkus, Lan Kluwe, R. Walraven, Georg Becker, E B Bröcker, V.-F. Mautner, Henning Hamm	2003	26
14	MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways International Immunology ·M. Leverkus	2003	30
15	Topical Psoralen Photochemotherapy With Lethal Outcome Archives of Dermatology ·(unknown), M. Leverkus, E.‐B. Bröcker, M. Goebeler	2001	9
16	Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230 British Journal of Dermatology ·M. Leverkus, Kailash C. Bhol, Aneta Peshnacka, Hendri H. Pas, Cassian Sitaru, Tony Ridley, E.-B. Bröcker, M. F. Jonkman, A. R. Ahmed, Detlef Zillikens	2001	49
17	Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development Cell Death and Differentiation ·Alexander D. McLellan, S. Vaghela, Thilo Mengling, Gary C. Starling, Peter A. Kiener, Rebecca Gold, Netanel Anor, M. Leverkus, Eckhart Kämpgen	2000	36
18	Effect of chronic wound fluid on fibroblasts Journal of Wound Care ·Tania J. Phillips, Paul J. Creevey, M. Leverkus, Hyun Gyu Park	1998	51
19	Thymidine dinucleotides mimic immunomodulatory effects of ultraviolet irradiation Journal of Investigative Dermatology ·M. Leverkus, Giri Srikanthan, Mark S. Eller, Zhuoxuan Shi, Jiuyu Liu	1997	4
20	Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma Melanoma Research ·Wolfgang Dummer, M.J. Herbut, EIP-AGRI Service Point, M. Leverkus, Tabea Moll, 鈴木陽一	1995	109

About M. Leverkus

M. Leverkus is a scholar working on Immunology, Dermatology, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (10 papers), RNA Interference and Gene Delivery (5 papers), NF-κB Signaling Pathways (5 papers), Autoimmune Bullous Skin Diseases (4 papers), Urticaria and Related Conditions (4 papers), Melanoma and MAPK Pathways (4 papers), Immunotherapy and Immune Responses (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). The work is most often cited by research in Immunology (458 citations), Dermatology (144 citations), Cancer Research (241 citations), Molecular Biology (832 citations) and Genetics (116 citations). M. Leverkus has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Henning Walczak, E B Bröcker, Thilo Mengling, Manfred Neumann, P H Krammer, Charles T. Rauch, Peter Geserick, Sebastian Horn, Maria Feoktistova and Sergij Goerdt. Their work appears in journals such as British Journal of Dermatology, Cell Death and Disease, Journal of the European Academy of Dermatology and Venereology, Cell Death and Differentiation and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact